← Back to Bills
S. 5237Senate119th Congress (2025-2027)In Committee

Stop Superbugs Act

Sponsored by Margaret Wood HassanSen. Margaret Wood Hassan (D-NH)
Introduced August 4, 2026

AI-Generated Summary

Updated August 11, 2026 at 5:51 AM UTC

The Stop Superbugs Act directs the director of the National Institute of Allergy and Infectious Diseases (NIAID) to fund a competitive grant for the Antibiotic Resistance Leadership Group. The grant is meant to create a clinical research network that tackles antibiotic‑resistant infections. It would support faster enrollment of trial participants, outreach in community settings, integration of new diagnostics with drugs, and collection of patient‑reported outcomes.

Key Provisions

  • NIAID must award a competitive grant to the Antibiotic Resistance Leadership Group to set up a clinical research network on antibiotic resistance.
  • The network must focus on rapid recruitment of trial participants, community‑based outreach for trial enrollment, pairing diagnostic tools with new antibiotics during trials, and developing patient‑reported outcome measures.
  • Appropriations are authorized for NIAID to provide whatever funding is needed to carry out these activities.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

1 earlier action
SenateIntro Referral Latest Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Health, Education, Labor, and Pensions Committee

August 4, 2026

View full timeline
SenateIntro Referral

Introduced in Senate

August 4, 2026

SenateIntro Referral

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Health, Education, Labor, and Pensions Committee

August 4, 2026

Bill Text

Latest available legislative text

Reading Mode
Latest
Raw Text PDF XML
Introduced in SenateIssued August 4, 2026

II

119th CONGRESS

2d Session

S. 5237

IN THE SENATE OF THE UNITED STATES

August 4, 2026

Ms. Hassan (for herself and Mr. Marshall) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions

A BILL

To require the Director of the National Institute of Allergy and Infectious Diseases to award a competitive grant for the Antibiotic Resistance Leadership Group for the purpose of facilitating a clinical research network on antibiotic resistance, and for other purposes.

1.

Short title

This Act may be cited as the Stop Superbugs Act.

2.

Funding for antibiotic resistance clinical research

(a)

In general

The Director of the National Institute of Allergy and Infectious Diseases shall award a competitive grant for the Antibiotic Resistance Leadership Group for the purpose of facilitating a clinical research network on antibiotic resistance, which shall include focuses on—

(1)

supporting rapid recruitment of clinical trial participants;

(2)

conducting clinical trial recruitment outreach in community settings;

(3)

supporting the pairing of diagnostic and pharmaceutical innovations during clinical trials; and

(4)

developing patient-reported outcomes in clinical studies.

(b)

Authorization of appropriations

There is authorized to be appropriated to the Director of the National Institute of Allergy and Infectious Diseases such sums as may be necessary to carry out subsection (a).